marketcaparena
Search

    PRAX

    Praxis Precision Medicines, Inc.

    Company overview

    Market capitalization
    $7.98B
    Employees
    168
    Latest publication
    2026-09-29
    About Praxis Precision Medicines, Inc.

    Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States. The company's platforms include Cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and Solidus to discover and develop antisense oligonucleotide. It also develops ulixacaltamide, a small molecule inhibitor of T-type calcium channels that in NDA for the treatment of essential tremor; relutrigine, a small molecule, which is in NDA for the treatment of SCN2A- and SCN8A-developmental and epileptic encephalopathies (DEE), as well as in Phase 3 trial for broad DEEs; vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain that is in Phase 3 trial for the treatment of adjunctive focal epilepsy, as well as in Phase 2 trial for monotherapy focal epilepsy; and Elsunersen, a clinical-stage ASO designed to selectively decrease SCN2A gene expression, which is in Phase 3 trial for the treatment of SCN2A-DEE. In addition, the company is developing product candidates in pre-clinical trial comprising PRAX-020 to treat KCNT1; PRAX-080 that targets PCDH19 mosaic expression disorders; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a cooperation and license agreement with RogCon Inc.; research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and research collaboration and license agreement to develop an iontophoretic transdermal patch for the delivery of ulixacaltamide. The company was formerly known as EpiPM Therapeutics, Inc. and changed its name to Praxis Precision Medicines, Inc. in October 2016. Praxis Precision Medicines, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ4 20222022-12-31 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USD
    Net Income-83,720,000USD-92,561,000USD-88,911,000USD-73,934,000USD-71,127,000USD-41,173,000USD-43,945,000USD-60,194,000USD
    Operating Income-96,904,000USD-105,860,000USD-97,044,000USD-78,359,000USD-76,067,000USD-41,453,000USD-44,290,000USD-60,394,000USD
    Total Revenue—0USD0USD0USD0USD0USD0USD0USD
    Cost Of Revenue—39,000USD77,506,000USD65,797,000USD63,006,000USD27,729,000USD30,439,000USD2,987,000USD
    Gross Profit—-39,000USD-77,506,000USD-65,797,000USD-63,006,000USD-27,729,000USD-30,439,000USD-2,987,000USD
    Research Development—77,987,000USD77,506,000USD65,797,000USD63,006,000USD28,329,000USD30,439,000USD43,620,000USD
    Selling General Administrative—27,873,000USD19,538,000USD12,562,000USD13,061,000USD12,724,000USD13,851,000USD16,373,999USD
    Total Operating Expenses—105,860,000USD19,538,000USD12,562,000USD13,061,000USD13,724,000USD13,851,000USD57,407,000USD
    Income Before Tax—-92,561,000USD-88,911,000USD-73,934,000USD-71,127,000USD-41,173,000USD-43,945,000USD-60,194,000USD
    Net Income From Continuing Ops—-92,561,000USD-88,911,000USD-73,934,000USD-71,127,000USD-41,173,000USD-43,945,000USD-60,194,000USD
    Ebit—-92,561,000USD-88,911,000USD-73,934,000USD-71,127,000USD-40,453,000USD-43,945,000USD-59,394,000USD
    Ebitda—-92,522,000USD-88,883,000USD-73,915,000USD-71,081,000USD-40,348,000USD-43,843,000USD-59,275,000USD
    Depreciation And Amortization—39,000USD28,000USD19,000USD46,000USD105,000USD102,000USD119,000USD
    Reconciled Depreciation—39,000USD28,000USD19,000USD46,000USD105,000USD102,000USD119,000USD
    Total Other Income Expense Net—13,299,000USD8,133,000USD4,425,000USD4,940,000USD280,000USD345,000USD200,000USD
    Unclassified Operating Expenses——-77,506,000USD-65,797,000USD-63,006,000USD-27,329,000USD-30,439,000USD-2,586,999USD
    Interest Expense—————105,000USD345,000USD200,000USD
    Income Tax Expense—————-280,000USD-345,000USD-200,000USD
    Tax Provision—————0USD0USD—
    Non Operating Income Net Other—————280,000USD345,000USD200,000USD
    Net Income Applicable To Common Shares—————-41,173,000USD-43,945,000USD-60,194,000USD
    SourceDisclosureVerifiedLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue0USD1,464,000USD0USD0USD0USD0USD
    Cost Of Revenue140,000USD1,171,000USD1,594,000USD746,000USD679,000USD1,000USD
    Gross Profit-140,000USD-1,171,000USD-1,594,000USD-746,000USD-679,000USD-1,000USD
    Research Development267,115,000USD155,040,000USD120,257,000USD44,976,000USD29,557,000USD18,820,000USD
    Selling General Administrative59,083,000USD59,946,000USD47,075,000USD16,992,000USD6,232,000USD3,899,000USD
    Total Operating Expenses326,058,000USD214,986,000USD167,332,000USD61,968,000USD35,789,000USD22,719,000USD
    Operating Income-326,198,000USD-214,986,000USD-167,332,000USD-61,968,000USD-35,789,000USD-22,719,000USD
    Income Before Tax-303,268,000USD-214,029,000USD-167,061,000USD-61,828,000USD-35,596,000USD-26,402,000USD
    Net Income-303,268,000USD-213,072,000USD-166,879,000USD-61,820,000USD-35,512,000USD-26,535,000USD
    Net Income From Continuing Ops-303,268,000USD-214,029,000USD-167,061,000USD-61,820,000USD-35,512,000USD-26,535,000USD
    Ebit-303,268,000USD-214,986,000USD-167,332,000USD-61,968,000USD-35,596,000USD-26,275,000USD
    Ebitda-303,128,000USD-214,567,000USD-167,150,000USD-61,918,000USD-34,917,000USD-26,274,000USD
    Depreciation And Amortization140,000USD419,000USD182,000USD50,000USD679,000USD1,000USD
    Reconciled Depreciation140,000USD419,000USD182,000USD50,000USD37,000USD1,000USD
    Total Other Income Expense Net22,930,000USD957,000USD271,000USD140,000USD193,000USD-3,683,000USD
    Interest Expense—419,000USD182,000USD190,000USD0USD127,000USD
    Income Tax Expense—-957,000USD-182,000USD-8,000USD-84,000USD133,000USD
    Tax Provision—-5,000USD5,000USD-8,000USD-84,000USD133,000USD
    Non Operating Income Net Other—957,000USD271,000USD140,000USD——
    Net Income Applicable To Common Shares—-214,029,000USD-167,061,000USD-70,323,000USD-40,682,000USD-29,223,000USD
    Interest Income———140,000USD193,000USD92,000USD
    Net Interest Income———140,000USD193,000USD-35,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,390,102,000USD1,460,202,000USD937,907,000USD396,388,000USD452,832,000USD478,736,000USD483,110,000USD416,256,000USD
    Cash And Equivalents474,761,000USD———————
    Cash And Short Term Investments1,400,000,000USD786,865,000USD599,331,000USD267,157,000USD301,275,000USD327,991,000USD392,567,000USD357,032,000USD
    Short Term Investments283,790,000USD250,532,000USD242,002,000USD117,630,000USD143,860,000USD162,424,000USD177,195,000USD188,387,000USD
    Long Term Investments615,290,000USD660,938,000USD326,757,000USD122,008,000USD145,369,000USD144,032,000USD76,961,000USD54,141,000USD
    Total Current Assets771,903,000USD797,774,000USD610,911,000USD273,844,000USD306,579,000USD333,575,000USD404,372,000USD360,048,000USD
    Other Current Assets13,352,000USD10,909,000USD11,580,000USD6,687,000USD5,304,000USD5,584,000USD11,805,000USD3,016,000USD
    Other Non Current Assets643,000USD———————
    Total Liabilities49,058,000USD———————
    Total Current Liabilities49,058,000USD50,241,000USD59,771,000USD52,883,000USD48,608,000USD39,522,000USD37,550,000USD32,861,000USD
    Other Current Liabilities24,585,000USD———————
    Total Stockholder Equity1,341,044,000USD1,409,961,000USD878,136,000USD343,505,000USD404,224,000USD439,214,000USD445,450,000USD382,666,000USD
    Total Equity Including Noncontrolling Interest1,341,044,000USD———————
    Property Plant Equipment Net1,493,000USD1,490,000USD239,000USD536,000USD884,000USD1,129,000USD1,361,000USD1,651,000USD
    Intangible Assets773,000USD———————
    Accounts Payable23,386,000USD31,158,000USD24,628,000USD30,819,000USD28,832,000USD22,909,000USD12,528,000USD15,010,000USD
    Short Term Debt1,087,000USD1,435,000USD110,000USD436,000USD755,000USD1,066,000USD1,259,000USD1,224,000USD
    Common Stock15,000USD15,000USD15,000USD14,000USD14,000USD14,000USD14,000USD14,000USD
    Retained Earnings-1,316,289,000USD-1,232,569,000USD-1,140,008,000USD-1,051,097,000USD-977,163,000USD-906,036,000USD-836,740,000USD-778,061,000USD
    Accumulated Other Comprehensive Income-2,672,000USD-1,594,000USD563,000USD500,000USD395,000USD659,000USD654,000USD1,331,000USD
    Total Liab—50,241,000USD59,771,000USD52,883,000USD48,608,000USD39,522,000USD37,660,000USD33,590,000USD
    Other Current Liab—17,648,000USD35,033,000USD21,628,000USD19,021,000USD15,547,000USD23,763,000USD15,457,000USD
    Capital Stock—15,000USD15,000USD14,000USD14,000USD14,000USD14,000USD14,000USD
    Cash—536,333,000USD357,329,000USD149,527,000USD157,415,000USD165,567,000USD215,372,000USD168,645,000USD
    Net Debt—-534,898,000USD-357,219,000USD-149,091,000USD-156,660,000USD-164,501,000USD-214,003,000USD-166,985,000USD
    Short Long Term Debt Total—1,435,000USD110,000USD436,000USD755,000USD1,066,000USD1,369,000USD1,660,000USD
    Property Plant Equipment Gross—1,490,000USD1,741,000USD536,000USD884,000USD1,129,000USD2,724,000USD1,651,000USD
    Common Stock Shares Outstanding—28,883,596shares22,504,676shares21,977,268shares21,474,827shares21,055,834shares19,980,179shares18,884,562shares
    Non Current Assets Total—662,428,000USD326,996,000USD122,544,000USD146,253,000USD145,161,000USD78,738,000USD56,208,000USD
    Non Current Liabilities Total—0USD0USD0USD0USD0USD110,000USD729,000USD
    Non Currrent Assets Other—660,938,000USD326,757,000USD122,008,000USD145,369,000USD144,032,000USD416,000USD416,000USD
    Net Working Capital—747,533,000USD551,140,000USD220,961,000USD257,971,000USD294,053,000USD366,822,000USD327,187,000USD
    Unclassified Non Current Assets—-660,938,000USD-326,757,000USD-122,008,000USD-145,369,000USD-144,032,000USD——
    Unclassified Equity—2,644,094,000USD2,017,551,000USD1,394,074,000USD1,380,964,000USD1,344,563,000USD1,281,508,000USD1,159,368,000USD
    Current Deferred Revenue———————1,170,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets937,907,000USD483,110,000USD87,948,000USD115,128,000USD292,747,000USD303,177,000USD47,694,000USD19,829,000USD
    Other Current Assets11,580,000USD11,805,000USD3,580,000USD10,351,000USD11,498,000USD5,718,000USD681,000USD1,176,000USD
    Total Liab59,771,000USD37,660,000USD18,279,000USD39,022,000USD41,935,000USD15,720,000USD7,581,000USD5,147,000USD
    Total Stockholder Equity878,136,000USD445,450,000USD69,669,000USD76,106,000USD250,812,000USD287,457,000USD40,113,000USD14,682,000USD
    Other Current Liab35,033,000USD23,763,000USD7,416,000USD14,845,000USD22,533,000USD10,869,000USD3,455,000USD1,754,000USD
    Common Stock15,000USD14,000USD13,000USD5,000USD5,000USD4,000USD1,000USD1,000USD
    Capital Stock15,000USD14,000USD13,000USD5,000USD5,000USD4,000USD1,000USD1,000USD
    Retained Earnings-1,140,008,000USD-836,740,000USD-653,921,000USD-530,644,000USD-316,615,000USD-149,554,000USD-81,009,000USD-41,365,000USD
    Cash357,329,000USD215,372,000USD81,300,000USD61,615,000USD138,704,000USD296,608,000USD44,815,000USD17,950,000USD
    Cash And Short Term Investments599,331,000USD392,567,000USD81,300,000USD100,489,000USD275,911,000USD296,608,000USD44,815,000USD17,950,000USD
    Total Current Assets610,911,000USD404,372,000USD84,880,000USD110,840,000USD287,409,000USD302,326,000USD45,496,000USD19,126,000USD
    Total Current Liabilities59,771,000USD37,550,000USD15,749,000USD35,522,000USD37,624,000USD15,720,000USD6,818,000USD5,145,000USD
    Net Debt-357,219,000USD-214,003,000USD-78,805,000USD-57,110,000USD-134,393,000USD-295,845,000USD-43,356,000USD-17,950,000USD
    Short Term Debt110,000USD1,259,000USD1,126,000USD1,005,000USD4,311,000USD763,000USD696,000USD—
    Short Long Term Debt Total110,000USD1,369,000USD2,495,000USD4,505,000USD4,311,000USD763,000USD1,459,000USD—
    Long Term Investments326,757,000USD76,961,000USD0USD—————
    Short Term Investments242,002,000USD177,195,000USD0USD38,874,000USD137,207,000USD0USD——
    Accounts Payable24,628,000USD12,528,000USD5,815,000USD14,672,000USD10,780,000USD4,088,000USD2,667,000USD3,391,000USD
    Property Plant Equipment Net239,000USD1,361,000USD2,652,000USD3,872,000USD4,866,000USD836,000USD1,578,000USD103,000USD
    Property Plant Equipment Gross1,741,000USD2,724,000USD3,657,000USD3,872,000USD4,866,000USD836,000USD1,578,000USD103,000USD
    Accumulated Other Comprehensive Income563,000USD654,000USD—-173,000USD-176,000USD-303,177,000USD-38,000USD-1,000USD
    Common Stock Shares Outstanding22,504,676shares17,906,794shares6,594,316shares3,073,116shares2,830,270shares2,551,236shares1,145,152shares884,717shares
    Non Current Assets Total326,996,000USD78,738,000USD3,068,000USD4,288,000USD5,338,000USD851,000USD2,198,000USD703,000USD
    Non Current Liabilities Total0USD110,000USD2,530,000USD3,500,000USD4,311,000USD4,851,000USD763,000USD2,000USD
    Non Currrent Assets Other326,757,000USD416,000USD416,000USD416,000USD472,000USD15,000USD620,000USD600,000USD
    Net Working Capital551,140,000USD366,822,000USD69,131,000USD76,495,000USD248,975,000USD286,606,000USD38,678,000USD13,981,000USD
    Unclassified Non Current Assets-326,757,000USD———————
    Unclassified Equity2,017,551,000USD1,281,508,000USD723,564,000USD606,913,000USD567,593,000USD740,180,000USD121,158,000USD56,046,000USD
    Current Deferred Revenue——1,392,000USD5,000,000USD————
    Unclassified Non Current Liabilities——2,530,000USD1,318,000USD4,311,000USD4,851,000USD——
    Other Liab———2,182,000USD———2,000USD
    Other Assets———416,000USD472,000USD769,000USD620,000USD600,000USD
    Net Tangible Assets———76,106,000USD250,812,000USD287,457,000USD-81,008,000USD-41,038,000USD
    Non Current Liabilities Other———————2,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation72,000USD
    Stock Based Compensation28,421,000USD
    Change To Liabilities-11,798,000USD
    Change In Working Capital-3,540,000USD
    Operating Cash Flow-163,694,000USD
    Capital Expenditures-307,000USD
    Net Investments-332,213,000USD
    Unclassified Investing Cash Flow-773,000USD
    Investing Cash Flow-333,293,000USD
    Net Common Stock Issuance-13,233,000USD
    Unclassified Financing Cash Flow627,236,000USD
    Financing Cash Flow614,003,000USD
    Change In Cash117,016,000USD
    End Cash Flow474,761,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-92,561,000USD-88,911,000USD-73,934,000USD-71,127,000USD-69,296,000USD-58,679,000USD-51,910,000USD-32,677,000USD
    Depreciation39,000USD28,000USD19,000USD-941,000USD47,000USD47,000USD-3,528,000USD107,000USD
    Stock Based Compensation17,112,000USD9,938,000USD7,447,000USD7,770,000USD8,786,000USD8,575,000USD12,432,000USD5,878,000USD
    Other Non Cash Items16,654,000USD9,531,000USD-442,000USD257,000USD-980,000USD-1,147,000USD17,690,000USD-1,301,000USD
    Change In Working Capital-10,183,000USD2,093,999USD2,172,000USD9,365,000USD8,736,000USD-4,918,000USD-2,184,000USD715,000USD
    Total Cash From Operating Activities-86,051,000USD-77,258,000USD-64,738,000USD-54,676,000USD-52,707,000USD-56,122,000USD-27,500,000USD-27,278,000USD
    Capital Expenditures-62,000USD0USD0USD-120,000USD-64,000USD0USD0USD0USD
    Free Cash Flow-86,113,000USD-77,258,000USD-64,738,000USD-54,796,000USD-52,707,000USD-56,122,000USD-27,500,000USD-27,278,000USD
    Investments-344,213,000USD-328,391,000USD50,413,000USD17,894,000USD-51,064,000USD-10,918,000USD49,566,000USD-195,922,000USD
    Total Cashflows From Investing Activities-344,275,000USD-328,391,000USD50,413,000USD17,894,000USD-51,064,000USD-10,918,000USD49,566,000USD-195,922,000USD
    Total Cash From Financing Activities609,330,000USD613,451,000USD6,437,000USD28,630,000USD53,966,000USD113,767,000USD1,436,000USD216,363,000USD
    Issuance Of Capital Stock621,235,000USD601,725,000USD6,000,000USD28,359,000USD54,904,000USD111,950,000USD1,236,000USD216,061,000USD
    Change In Cash179,003,999USD207,802,000USD-7,888,000USD-8,152,000USD-49,805,000USD46,727,000USD23,502,000USD-6,837,000USD
    Begin Period Cash Flow357,329,000USD149,527,000USD157,415,000USD165,983,000USD215,372,000USD169,061,000USD145,559,000USD152,396,000USD
    End Period Cash Flow536,332,999USD357,329,000USD149,527,000USD157,831,000USD165,567,000USD215,788,000USD169,061,000USD145,559,000USD
    Other Cashflows From Financing Activities-12,923,000USD-819,000USD-52,000USD288,000USD-1,195,000USD982,000USD200,000USD580,000USD
    Unclassified Operating Cash Flow-17,112,000USD-9,937,999USD——————
    Unclassified Financing Cash Flow—12,545,000USD————1,237,000USD215,920,000USD
    Other Cashflows From Investing Activities———64,000USD-64,000USD———
    Sale Purchase Of Stock——————-1,000USD-137,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-303,268,000USD-182,819,000USD-123,277,000USD-214,029,000USD-167,061,000USD-61,820,000USD-35,512,000USD-26,535,000USD
    Depreciation-3,452,000USD358,000USD432,000USD419,000USD182,000USD50,000USD679,000USD1,000USD
    Stock Based Compensation33,941,000USD41,360,000USD24,857,000USD28,593,000USD22,693,000USD5,211,000USD668,000USD579,000USD
    Other Non Cash Items1,033,000USD-1,577,000USD-121,000USD1,755,000USD1,412,000USD696,000USD668,000USD127,000USD
    Change In Working Capital22,678,000USD10,921,000USD-13,027,000USD-1,781,000USD16,133,000USD3,240,000USD1,378,000USD1,459,000USD
    Total Cash From Operating Activities-249,068,000USD-131,757,000USD-111,136,000USD-185,043,000USD-124,554,000USD-52,623,000USD-32,787,000USD-20,721,000USD
    Capital Expenditures-56,000USD0USD-50,000USD-444,000USD-1,050,000USD-4,000USD-103,000USD-63,000USD
    Free Cash Flow-249,124,000USD-131,757,000USD-111,186,000USD-185,487,000USD-125,604,000USD-52,623,000USD-32,890,000USD-20,784,000USD
    Investments-311,092,000USD-248,494,000USD61,594,000USD97,333,000USD-139,470,000USD-139,470,000USD-103,000USD-63,000USD
    Total Cashflows From Investing Activities-311,148,000USD-248,494,000USD38,950,000USD96,889,000USD-140,520,000USD4,000USD-103,000USD-63,000USD
    Total Cash From Financing Activities702,173,000USD514,323,000USD91,871,000USD10,465,000USD107,586,000USD304,416,000USD59,755,000USD37,804,000USD
    Issuance Of Capital Stock690,988,000USD511,998,000USD92,798,000USD9,561,000USD105,714,000USD334,328,000USD60,388,000USD36,804,000USD
    Change In Cash141,957,000USD134,072,000USD19,685,000USD-77,689,000USD-157,488,000USD251,793,000USD26,865,000USD17,020,000USD
    Begin Period Cash Flow215,788,000USD81,716,000USD62,031,000USD139,720,000USD297,208,000USD45,415,000USD17,950,000USD1,530,000USD
    End Period Cash Flow357,745,000USD215,788,000USD81,716,000USD62,031,000USD139,720,000USD297,208,000USD44,815,000USD18,550,000USD
    Other Cashflows From Financing Activities-2,089,000USD2,325,000USD695,000USD904,000USD2,635,000USD88,000USD60,388,000USD36,804,000USD
    Unclassified Financing Cash Flow13,274,000USD—91,313,000USD10,632,000USD4,091,000USD335,024,000USD—-36,804,000USD
    Sale Purchase Of Stock——-137,000USD-260,000USD100,860,000USD-30,000,000USD0USD—
    Unclassified Investing Cash Flow——-22,594,000USD-97,333,000USD139,470,000USD139,478,000USD——
    Change To Liabilities———-6,573,000USD7,267,000USD960,000USD-837,000USD1,667,000USD
    Dividends Paid———-811,000USD—-696,000USD——
    Cash And Cash Equivalents Changes———-77,689,000USD-157,488,000USD251,797,000USD——
    Other Cashflows From Investing Activities———97,333,000USD-139,470,000USD———
    Unclassified Operating Cash Flow————2,087,000USD——3,648,000USD
    Net Borrowings———————1,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.